NASDAQ: ALLR
Allarity Therapeutics Inc Stock Ownership - Who owns Allarity Therapeutics?

Insider buying vs selling

Have Allarity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeremy R. GraffPresident and Chief Development Officer2024-09-30118,483$2.11
$250.00kBuy

1 of 1

ALLR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALLR insiders and whales buy or sell their stock.

ALLR Shareholders

What type of owners hold Allarity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Leon Sass6.38%1,086,238$1.08MInsider
Thomas Jensen2.33%396,734$393.16kInsider
Jeremy R. Graff1.55%262,924$260.56kInsider
Steen Knudsen0.73%124,976$123.85kInsider
Alexander Epshinsky0.50%85,051$84.29kInsider
Stonepine Capital Management LLC0.40%67,289$66.68kInstitution
Duncan Moore0.13%22,672$22.47kInsider
Goldman Sachs Group Inc0.12%20,616$20.43kInstitution
Citigroup Inc0.07%12,294$12.18kInstitution
Tower Research Capital LLC Trc0.03%4,266$4.23kInstitution

1 of 2

ALLR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLR0.61%11.67%Net Buying
EQ24.45%40.38%Net Selling
UBX18.46%51.20%Net SellingNet Selling
NRXS5.54%37.14%Net BuyingNet Buying
ABP3.04%62.62%

Allarity Therapeutics Stock Ownership FAQ

Who owns Allarity Therapeutics?

Allarity Therapeutics (NASDAQ: ALLR) is owned by 0.61% institutional shareholders, 11.67% Allarity Therapeutics insiders, and 87.72% retail investors. Leon Sass is the largest individual Allarity Therapeutics shareholder, owning 1.09M shares representing 6.38% of the company. Leon Sass's Allarity Therapeutics shares are currently valued at $1.10M.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.